microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer

Author(s): Francesca De Santa, Ilaria Iosue, Alberto Del Rio, Francesco Fazi

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 4 , 2013

Become EABM
Become Reviewer
Call for Editor


The deregulation of microRNAs expression and activity is frequently observed in a wide variety of human pathologies including cancer. Accordingly, growing evidence indicates that the targeting of microRNAs biogenesis and pathways is emerging as a central tool for the development of novel RNA-based drugs and therapies to defeat diseases in humans. In this review we describe the various strategies that can be used to target microRNAs and specific RNA-binding proteins, involved in the regulation of their production, localization, stability and activity, in human cancer and cardiovascular diseases. We also focus on the efforts that are currently made to enhance the potency and stability of these therapeutic agents and their delivery to modulate in vivo microRNAs pathways. Finally, we present structural data on proteins that belong to the microRNA pathway for small molecules-based target therapy design.

Keywords: microRNA, drosha, exportin-5, dicer, argonaute proteins, RNA-based drugs and therapies, small molecules design, crystallography, NMR

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 10 December, 2012
Page: [745 - 764]
Pages: 20
DOI: 10.2174/1381612811306040745
Price: $65

Article Metrics

PDF: 47